Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Shimrit Ringelstein Harlev"'
Autor:
Israel Henig, Jonathan Isenberg, Dana Yehudai-Ofir, Ronit Leiba, Shimrit Ringelstein-Harlev, Ron Ram, Batia Avni, Odelia Amit, Sigal Grisariu, Tehila Azoulay, Ilana Slouzkey, Tsila Zuckerman
Publikováno v:
Vaccines, Vol 11, Iss 4, p 775 (2023)
COVID-19-related mortality among hematopoietic stem cell transplantation (HSCT) recipients in the pre-vaccine era ranged between 22 and 33%. The Pfizer/BioNTech BNT162b2 vaccine demonstrated significant immunogenicity and efficacy in the healthy popu
Externí odkaz:
https://doaj.org/article/94348d0ee029449fa530060c7aaf3ce8
Autor:
Ronit Gurion, Uri Rozovski, Gilad Itchaki, Anat Gafter-Gvili, Chiya Leibovitch, Pia Raanani, Haim Ben-Zvi, Moran Szwarcwort, Mor Taylor-Abigadol, Eldad J. Dann, Nurit Horesh, Tsofia Inbar, Inna Tzoran, Noa Lavi, Riva Fineman, Shimrit Ringelstein-Harlev, Netanel A. Horowitz
Publikováno v:
Haematologica, Vol 107, Iss 3 (2021)
Patients with lymphoma, especially those treated with anti-CD20 monoclonal antibodies, suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess the ability of lymphoma patients to generate a sufficient humoral res
Externí odkaz:
https://doaj.org/article/c1dde55d416f4a95b6372ab8f7d798dd
Autor:
Ofrat Beyar Katz, Chava Perry, Sigal Grisariu‐Greenzaid, Dana Yehudai‐Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein‐Harlev, Yael Bar‐On, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Publikováno v:
European Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68913e150ac552a059e5cb08a67beca5
https://doi.org/10.1111/ejh.13968
https://doi.org/10.1111/ejh.13968
Autor:
Irit Avivi, Chava Perry, Yafit Segman, Odelia Amit, Yaeli Bar-On, Ofrat Beyer Katz, Ronit Gold, Elena Ribakovsky, Abraham Avigdor, Vladimir Vainstein, Neta Goldschmidt, Shimrit Ringelstein-Harlev, Netanel A. Horowitz, Odit Gutwein, Ronit Gurion, Gilad Itchaki, Uri Abadi, Anatoly Nemets, Orit Sofer, Miri Vezker, Tamar Tadmor, Najib Dally, Kalman Filanovsky, Merav Leiba, Nadav Sarid, Noam Benyamini, Efrat Luttwak, Yair Herishanu, Ron Ram
Publikováno v:
Annals of Hematology. 101:755-762
Polatuzumab (Pola)-based regimens and chimeric antigen receptor T (CAR T) cells provide superior outcome compared to conventional chemoimmunotherapy in patients with relapsed/refractory diffuse large B cell lymphoma (R/R DLBCL). Choosing between thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088cdff2dd6df4986e6e0e0f3e5be98f
https://doi.org/10.1007/s00277-021-04749-9
https://doi.org/10.1007/s00277-021-04749-9
Publikováno v:
European journal of haematology.
In chronic lymphocytic leukemia (CLL), the immune system is skewed towards a suppressive milieu. Levels of thrombopoietin (TPO), promoting cellular immune regulatory activity in immune thrombocytopenic purpura, were shown to be elevated in CLL patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c455ec13d1b0d099503d2d8ee5415aaa
https://pubmed.ncbi.nlm.nih.gov/36478591
https://pubmed.ncbi.nlm.nih.gov/36478591
Autor:
Ofrat Beyar-Katz, Chava Perry, Yael Bar-On, Sigal Grisariu, Dana Yehudai-Ofir, Efrat Luttwak, Batia Avni, Tsila Zuckerman, Inbal Sdayoor, Polina Stepensky, Shimrit Ringelstein-Harlev, Diana Libster, Liat Sharvit, Odelia Amit, Uri Greenbaum, Ronit Gold, Yair Herishanu, Noam Benyamini, Irit Avivi, Ron Ram
Chimeric antigen receptor T-cells (CAR-T) are widely used for the treatment of relapsed/refractory Diffuse large B cell lymphoma (DLBCL). The data for CAR-T cell therapy in patients with extra-nodal(EN) lymphoma is restricted. We included 126 consecu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5855462c6ce33322e2ba406612a76c9f
https://doi.org/10.21203/rs.3.rs-2262627/v1
https://doi.org/10.21203/rs.3.rs-2262627/v1
Autor:
Tehila Azoulay, Ilana Slouzky, Michal Karmona, Margarita Filatov, Michal Hayun, Yishai Ofran, Galit Sarig, Shimrit Ringelstein-Harlev
Publikováno v:
Cancer immunology, immunotherapy : CII.
While natural killer (NK) cells are essential players in detection and elimination of malignant cells, these surveillance properties can be compromised by cancer cells. Since NK cell education primarily occurs in the bone marrow and lymphoid tissue,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f2bed0a54a351ea94177b7065da04e
https://pubmed.ncbi.nlm.nih.gov/36048214
https://pubmed.ncbi.nlm.nih.gov/36048214
Autor:
Tareq Artul, Nissim Haim, Michael Litvak, Ali Jabareen, Suheir Assady, Nethanel Horowitz, Razan Sakran, Edna Efrati, Gai Milo, Daniel Kurnik, Shimrit Ringelstein-Harlev
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(2)
Introduction Acute kidney injury (AKI) after high dose methotrexate (HD-MTX) is associated with delayed MTX-excretion and life-threatening toxicity. Glucapridase, the recommended therapy, is expensive and not always available. Case series We describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9edaedb7e5c25cd99cd9dcc62ff8d05b
https://pubmed.ncbi.nlm.nih.gov/34668443
https://pubmed.ncbi.nlm.nih.gov/34668443
Autor:
Riva Fineman, Dvora Sahar, Nivin Moustafa-Hawash, Shimrit Ringelstein-Harlev, Nuhad Haddad, Dana Yehudai-Ofir, Jacob M. Rowe, Yuval Nov, Ofrat Beyar-Katz, Noa Lavi, Yishai Ofran, Tsila Zuckerman, Israel Henig
Publikováno v:
Leukemia & Lymphoma. 60:2449-2456
Autologous stem cell transplantation (ASCT), intensifying anti-leukemic effects without significant treatment-related mortality (TRM), is particularly appealing in AML with favorable genetic/molecular profile. This study retrospectively evaluated the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c37d52a38b5d8ec750a0781443a23143
https://doi.org/10.1080/10428194.2019.1594214
https://doi.org/10.1080/10428194.2019.1594214
Publikováno v:
Rambam Maimonides Medical Journal, Vol 5, Iss 4, p e0027 (2014)
Achievement of complete response (CR) to therapy in chronic lymphocytic leukemia (CLL) has become a feasible goal, directly correlating with prolonged survival. It has been established that the classic definition of CR actually encompasses a variety
Externí odkaz:
https://doaj.org/article/98e150baa142450ab0938b5fd6f2e1b4